S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Tokai Pharmaceuticals Presents Updated Phase 2 Data on Galeterone in Patients with Advanced Prostate Cancer at ESMO 2014|
|Tokai Pharmaceuticals Announces Updated Phase 2 Data on Galeterone in Patients with Advanced Prostate Cancer to be Presented at the ESMO 2014 Congress|
|Tokai Pharmaceuticals Reports Third Quarter 2014 Financial Results|
|Tokai Pharmaceuticals Presents Updated Interim Galeterone ARMOR2 Data Showing Activity in Patients with Castration-Resistant Prostate Cancer (CRPC) Including Those Showing a Variant Form of Prostate Cancer Resistant to Hormone Therapy|
|Tokai Pharmaceuticals Announces Interim Phase 2 Data on Galeterone in Patients with Advanced Prostate Cancer to be Presented at the EORTC-NCI-AACR Symposium|
|Tokai Pharmaceuticals to Present at Upcoming Healthcare Investor Conferences|
|Tokai Pharmaceuticals Announces Pricing of Initial Public Offering (2014/9/17)|
|Tokai Pharmaceuticals Announces Closing of Initial Public Offering|
|Tokai Pharmaceuticals, Inc. (Nasdaq: TKAI) to Ring The Nasdaq Stock Market Opening Bell|
|Japanese stocks snap losing streak (2014/10/24)|
Click above to view more mutual fund data and stats for 9729 - TOKAI Corp.